miércoles, 25 de octubre de 2023

FDA approves ivosidenib for myelodysplastic syndromes

https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-ivosidenib-myelodysplastic-syndromes?utm_medium=email&utm_source=govdelivery

No hay comentarios:

Publicar un comentario